Merck & Co., Inc.

Symbol: MRK.PA

EURONEXT

101.4

EUR

Market price today

  • 762.4384

    P/E Ratio

  • -59.7531

    PEG Ratio

  • 257.30B

    MRK Cap

  • 0.03%

    DIV Yield

Merck & Co., Inc. (MRK-PA) Stock Price & Analysis

Shares Outstanding

2570.1M

Gross Profit Margin

0.73%

Operating Profit Margin

0.04%

Net Profit Margin

0.01%

Return on Assets

0.00%

Return on Equity

0.01%

Return on Capital Employed

0.03%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers—General
CEO:Mr. Robert M. Davis J.D.
Full-time employees:67000
City:Kenilworth
Address:2000 Galloping Hill Road
IPO:1946-06-15
CIK:

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

General Outlook

In simple terms, Merck & Co., Inc. has 2570.1 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.732% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.043%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.006%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.003% return, is a testament to Merck & Co., Inc.'s adeptness in optimizing resource deployment. Merck & Co., Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.009%. Furthermore, the proficiency of Merck & Co., Inc. in capital utilization is underscored by a remarkable 0.032% return on capital employed.

Stock Prices

Merck & Co., Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $103.800003, while its low point bottomed out at $102.599998. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Merck & Co., Inc.'s stock market.

Liquidity Ratios

Analyzing MRK.PA liquidity ratios reveals its financial health of the firm. The current ratio of 125.20% gauges short-term asset coverage for liabilities. The quick ratio (67.88%) assesses immediate liquidity, while the cash ratio (26.62%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio125.20%
Quick Ratio67.88%
Cash Ratio26.62%

Profitability Ratios

MRK.PA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 3.14% underscores its earnings before tax deductions. The effective tax rate stands at 80.04%, revealing its tax efficiency. The net income per EBT, 19.32%, and the EBT per EBIT, 72.65%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 4.33%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin3.14%
Effective Tax Rate80.04%
Net Income per EBT19.32%
EBT per EBIT72.65%
EBIT per Revenue4.33%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.25, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding68
Days of Inventory Outstanding144
Operating Cycle206.75
Days of Payables Outstanding89
Cash Conversion Cycle118
Receivables Turnover5.81
Payables Turnover4.11
Inventory Turnover2.54
Fixed Asset Turnover2.61
Asset Turnover0.56

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 5.09, and free cash flow per share, 3.58, depict cash generation on a per-share basis. The cash per share value, 2.78, showcases liquidity position. A payout ratio of 20.40 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.22, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share5.09
Free Cash Flow per Share3.58
Cash per Share2.78
Payout Ratio20.40
Operating Cash Flow Sales Ratio0.22
Free Cash Flow to Operating Cash Flow Ratio0.70
Cash Flow Coverage Ratio0.37
Short Term Coverage Ratio9.48
Capital Expenditure Coverage Ratio3.37
Dividend Paid and Capex Coverage Ratio1.15
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 32.86%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.93, we discern the balance between debt and equity financing. The long-term debt to capitalization, 47.27%, and total debt to capitalization, 48.26%, ratios shed light on its capital structure. An interest coverage of 2.30 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio32.86%
Debt Equity Ratio0.93
Long Term Debt to Capitalization47.27%
Total Debt to Capitalization48.26%
Interest Coverage2.30
Cash Flow to Debt Ratio0.37
Company Equity Multiplier2.84

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 23.70, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.14, reflects the portion of profit attributed to each share. The book value per share, 14.81, represents the net asset value distributed per share, while the tangible book value per share, -0.62, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share23.70
Net Income Per Share0.14
Book Value Per Share14.81
Tangible Book Value Per Share-0.62
Shareholders Equity Per Share14.81
Interest Debt Per Share14.27
Capex Per Share-1.52

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 312,137,666,624, captures the company's total value, considering both debt and equity. Income quality, 34.50, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 36.75%, indicates the value of non-physical assets, and capex to operating cash flow, -29.70%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value312,137,666,624
Income Quality34.50
Research and Development to Revenue50.79%
Intangibles to Total Assets36.75%
Capex to Operating Cash Flow-29.70%
Capex to Revenue-6.43%
Capex to Depreciation-99.77%
Stock-Based Compensation to Revenue1.07%
Graham Number6.92
Return on Tangible Assets0.54%
Graham Net Net-20.10
Working Capital6,474,000,000
Tangible Asset Value-1,573,000,000
Net Current Asset Value-36,872,000,000
Invested Capital1
Average Receivables9,899,500,000
Average Payables4,093,000,000
Average Inventory6,134,500,000
Days Sales Outstanding63
Days Payables Outstanding89
Days of Inventory On Hand144
ROIC1.01%
ROE0.01%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 7.41, and the price to book ratio, 7.41, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.66, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 30.63, and price to operating cash flows, 21.40, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio7.41
Price to Book Ratio7.41
Price to Sales Ratio4.66
Price Cash Flow Ratio21.40
Price Earnings to Growth Ratio-59.75
Enterprise Value Multiple55.28
Price Fair Value7.41
Price to Operating Cash Flow Ratio21.40
Price to Free Cash Flows Ratio30.63
Price to Tangible Book Ratio7.55
Enterprise Value to Sales5.19
Enterprise Value Over EBITDA41.42
EV to Operating Cash Flow24.00
Earnings Yield0.13%
Free Cash Flow Yield3.22%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Merck & Co., Inc. (MRK.PA) on the EURONEXT in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 762.438 in 2024.

What is the ticker symbol of Merck & Co., Inc. stock?

The ticker symbol of Merck & Co., Inc. stock is MRK.PA.

What is company IPO date?

IPO date of Merck & Co., Inc. is 1946-06-15.

What is company current share price?

Current share price is 101.400 EUR.

What is stock market cap today?

The market cap of stock today is 257296416000.000.

What is PEG ratio in 2024?

The current -59.753 is -59.753 in 2024.

What is the number of employees in 2024?

In 2024 the company has 67000.